BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider of outpatient dialysis services, today announced the appointment of Jason Boucher as Vice President and Chief Financial Officer (CFO) effective October 1, 2018. Mr. Boucher will succeed Jonathan (Jon) Wilcox, who will be leaving the Company on September 30, 2018 for another opportunity. Mr. Wilcox and Mr. Boucher will work closely together during this time period to ensure a smooth transition.

Mr. Boucher, 46, currently serves as the Company’s Vice President of Finance, Chief Accounting Officer and Treasurer. Mr. Boucher has more than 20 years of leadership experience in finance and accounting roles, including seven years at the Company, and more than eight years with other publicly-traded companies. Mr. Boucher will report to Chairman and CEO Joseph (Joe) Carlucci, and he will lead ARA’s corporate finance department and oversee accounting, tax, treasury, financial planning and revenue cycle management. Mr. Boucher is a Certified Public Accountant, and he received his B.S. from Plymouth State College and his M.B.A. from Suffolk University’s Sawyer School of Management. The Company has retained an executive search firm to fill the Vice President of Finance role during or shortly after the CFO transition period.

“On behalf of the entire Company, I want to thank Jon for his many contributions to ARA over the past nine years,” said Mr. Carlucci. “Our Company has benefited greatly from Jon’s strong judgment and his outstanding financial and operational expertise, and we wish him the best in his future endeavors.”

Mr. Carlucci continued, “Jason is a talented individual, a strong leader and well-respected within our Company, as well as among our physician partners. I am proud that the experience of our management team has positioned ARA to fill the CFO role in a seamless manner as a result of our strong bench.”

“I am fortunate to have worked with so many outstanding people with whom I have been part of ARA’s growth and success over the past nine years,” Mr. Wilcox said. “My focus now is on supporting Jason and the entire team to ensure a seamless and effective transition.”

“Jon has done a great job leading our team, and I am very excited about the opportunity to succeed him as CFO,” said Mr. Boucher. “I look forward to continuing to work closely with the Company’s leadership team as we capitalize on the many growth opportunities ahead of us.”

2018 Outlook for Adjusted EBITDA-NCI:

The Company is also reiterating its recently updated guidance for 2018 Adjusted EBITDA-NCI to be in a range of $105 million to $111 million.

The Company is not providing a quantitative reconciliation of our Non-GAAP outlook to the corresponding GAAP information because the GAAP measures that we exclude from our Non-GAAP outlook are not available without unreasonable effort on a forward-looking basis due to their unpredictability, high variability, complexity and low visibility. These excluded GAAP measures include noncontrolling interests, interest expense, income taxes, and other charges. We expect the variability of these charges to have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.

About American Renal Associates

American Renal Associates (“ARA”) is a leading provider of outpatient dialysis services in the United States. As of March 31, 2018, ARA operated 228 dialysis clinic locations in 26 states and the District of Columbia serving approximately 15,700 patients with end stage renal disease. ARA operates principally through a physician partnership model, in which it partners with approximately 400 local nephrologists to develop, own and operate dialysis clinics. ARA’s Core Values emphasize taking good care of patients, providing physicians with clinical autonomy and operational support, hiring and retaining the best possible staff and providing best practices management services. For more information about American Renal Associates, visit www.americanrenal.com.